⚠ A Skill Learned Once Can Be Learned AgainModerate threat
Intuitive Surgical (ISRG) — threat to the moat
The contest is decided in residency programmes, not operating rooms, and a challenger can pay for those.
Retraining a surgical department is expensive, disruptive and slow. It is not impossible, and every element of the barrier has a price a competitor can pay.
Medtronic and Johnson & Johnson are both named in Intuitive's own competition disclosure1, and both have what a challenger normally lacks: existing relationships with the same hospitals, existing sales forces in the same operating rooms, and the capital to fund proctoring, simulators and free training for as long as it takes. Neither needs the robotics programme to pay for itself in year one.
The place this contest is actually decided is not the operating room but the residency. A surgeon trained on one platform during residency carries that fluency for a career, and teaching hospitals are precisely the institutions a challenger will subsidise hardest. Intuitive knows this; its training pathways explicitly cover "residents and fellows"2.
There is a technological version of the same argument. Intuitive's own filing observes that "the entrance or emergence of competition validates MIS and robotic-assisted surgery"3, which is true and double-edged: a market with several credible platforms is a market where surgeons expect to be multi-platform, as they already are with laparoscopic instrument brands.
What to watch is not a competitor's system placements, which will be small for years. It is Intuitive's utilisation. If procedures per system per year stop rising while the installed base keeps growing, surgeons are spreading their cases across more platforms — and utilisation is a number Intuitive reports every quarter.
- ReportedMedtronic and Johnson & Johnson are both named in Intuitive's own competition disclosure, and both have what a challenger normally lacks: existing relationships with the same hospitals, existing sales forces in the same operating rooms,...Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 1 Business: competition, intellectual property and government regulation (the fourteen named competitors, more than 5,600 patents in force and 2,500 pending, Class II devices cleared under section 510(k) on substantial equivalence, special controls, field actions and recalls) — FY2025 · publ. February 3, 2026 · source ↗
- ReportedIntuitive knows this; its training pathways explicitly cover "residents and fellows".Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 1 Business (the da Vinci and Ion platforms, instruments with a use count enforced in the instrument itself, training pathways and SimNow, enabling technologies, manufacturing sites, employees by function, and the seasonality of benign procedures) — FY2025 · publ. February 3, 2026 · source ↗
- ReportedIntuitive's own filing observes that "the entrance or emergence of competition validates MIS and robotic-assisted surgery", which is true and double-edged: a market with several credible platforms is a market where surgeons expect to be...Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 1 Business: competition, intellectual property and government regulation (the fourteen named competitors, more than 5,600 patents in force and 2,500 pending, Class II devices cleared under section 510(k) on substantial equivalence, special controls, field actions and recalls) — FY2025 · publ. February 3, 2026 · source ↗